Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial

Mesenchymal stromal cells for treatment of arthritis

(2014) J.F. Swart et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Washing red cells after leucodepletion does not decrease human leukocyte antigen sensitization risk in patients with chronic kidney disease

(2014) Antony Aston et al.   PEDIATRIC NEPHROLOGY

Human Umbilical Cord Mesenchymal Stem Cell Therapy for Patients with Active Rheumatoid Arthritis: Safety and Efficacy

(2013) Liming Wang et al.   STEM CELLS AND DEVELOPMENT

Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease

(2012) Gerd R Burmester et al.   ANNALS OF THE RHEUMATIC DISEASES

The allogeneic umbilical cord mesenchymal stem cells regulate the function of T helper 17 cells from patients with rheumatoid arthritis in an in vitro co-culture system

(2012) Qin Wang et al.   BMC MUSCULOSKELETAL DISORDERS

Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis

(2012) Kentaro Akiyama et al.   Cell Stem Cell

Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?

(2012) Matthew D Griffin et al.   IMMUNOLOGY AND CELL BIOLOGY

Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials

(2012) Manoj M. Lalu et al.   PLoS One

Infections and Biologic Therapy in Rheumatoid Arthritis

(2012) Kevin L. Winthrop   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Assessing the safety of biologic agents in patients with rheumatoid arthritis

(2012) A. Rubbert-Roth   RHEUMATOLOGY

Immunomodulatory properties and therapeutic application of mesenchymal stem cells

(2011) M. Shi et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Allogeneic mesenchymal stem cells transplantation in patients with refractory RA

(2011) Jun Liang et al.   CLINICAL RHEUMATOLOGY

Therapeutic Applications of Mesenchymal Stromal Cells: Paracrine Effects and Potential Improvements

(2011) Joyce Doorn et al.   TISSUE ENGINEERING PART B-REVIEWS

Defining the risks of mesenchymal stromal cell therapy

(2010) Darwin J. Prockop et al.   CYTOTHERAPY

Immunological Aspects of Allogeneic Mesenchymal Stem Cell Therapies

(2010) Matthew D. Griffin et al.   HUMAN GENE THERAPY

Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis

(2009) E Gonzalez-Rey et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells

(2009) Manuel A. González et al.   ARTHRITIS AND RHEUMATISM

Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation

(2009) K. Tarte et al.   BLOOD

Long-term Cultures of Bone Marrow–Derived Human Mesenchymal Stem Cells Frequently Undergo Spontaneous Malignant Transformation

(2009) Gro Vatne Røsland et al.   CANCER RESEARCH

Mesenchymal Stem Cells Prevent the Rejection of Fully Allogenic Islet Grafts by the Immunosuppressive Activity of Matrix Metalloproteinase-2 and -9

(2009) Y. Ding et al.   DIABETES

Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss ofCdkn2

(2009) Alexander B Mohseny et al.   JOURNAL OF PATHOLOGY

Pulmonary thrombosis in the mouse following intravenous administration of quantum dot-labeled mesenchymal cells

(2009) Yuval Ramot et al.   Nanotoxicology